The abstract is read at the publisher; the summary is JClub's.
Metabolic state is linked to cell therapy differentiation and maturity, and metabolic shifts are being explored to improve potency in ways that could enable scalable, controlled manufacturing workflows.
- Why it matters: Current methods to steer cell phenotype and potency are limited in efficacy, scalability, and cost-effectiveness, creating a need for more process-relevant control levers.
- What they did: The work reviews recent studies that use metabolic shifts to target potency, aiming to connect metabolism with cell fate and inform bioprocess design.
- The result: Translating these metabolism-informed strategies may accelerate bioprocess development and support scalable, tightly controlled, and affordable manufacturing for functional cell therapy products.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.